Boothbay Fund Management’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-120,584
| Closed | -$156K | – | 1677 |
|
|
2023
Q3 | $156K | Sell |
120,584
-61,140
| -34% | -$78.9K | ﹤0.01% | 1283 |
|
|
2023
Q2 | $240K | Sell |
181,724
-245,679
| -57% | -$324K | 0.01% | 1210 |
|
|
2023
Q1 | $302K | Buy |
+427,403
| New | +$302K | 0.01% | 1280 |
|
|
2022
Q3 | – | Sell |
-55,532
| Closed | -$62K | – | 2171 |
|
|
2022
Q2 | $62K | Sell |
55,532
-27,051
| -33% | -$30.2K | ﹤0.01% | 1790 |
|
|
2022
Q1 | $92K | Hold |
82,583
| – | – | ﹤0.01% | 1729 |
|
|
2021
Q4 | $132K | Sell |
82,583
-4,837
| -6% | -$7.73K | ﹤0.01% | 1484 |
|
|
2021
Q3 | $212K | Sell |
87,420
-40,628
| -32% | -$98.5K | 0.01% | 1302 |
|
|
2021
Q2 | $406K | Sell |
128,048
-20,000
| -14% | -$63.4K | 0.01% | 966 |
|
|
2021
Q1 | $499K | Buy |
148,048
+20,000
| +16% | +$67.4K | 0.02% | 767 |
|
|
2020
Q4 | $458K | Sell |
128,048
-5,586
| -4% | -$20K | 0.02% | 652 |
|
|
2020
Q3 | $350K | Buy |
+133,634
| New | +$350K | 0.02% | 657 |
|